The most important financial indicators for the company Blutrot Medicine Srl - Unique Identification Number 35019782:
sales in 2023 was
66.271
euro, registering a net profit of
1.887
euro and having an average number of
4
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta stomatologica having the NACE code 8623.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 75.5%, from 37.880 euro in the year 2022, to 66.271 euro in 2023.
The Net Profit increased by 1.037 euro, from 852 euro in 2022, to 1.887 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Blutrot Medicine Srl - CUI 35019782
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
19.706
16.969
14.299
11.697
8.719
8.554
41.410
37.509
37.648
Current Assets
-
2.286
323
302
849
618
591
2.058
5.642
13.499
Inventories
-
195
194
190
187
0
0
671
2.491
4.796
Receivables
-
0
0
0
193
0
0
344
660
5.452
Cash
-
2.091
129
112
469
618
591
1.043
2.491
3.251
Shareholders Funds
-
-848
-4.297
-2.946
-2.989
-2.527
-2.479
-3.170
-2.328
-435
Social Capital
-
45
45
44
43
42
41
40
41
40
Debts
-
3.411
21.589
3.407
3.994
2.812
2.743
39.698
40.760
48.823
Income in Advance
-
19.430
16.807
14.140
11.541
9.052
8.880
6.941
4.865
2.759
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8623 - 8623"
CAEN Financial Year
8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
13.499 euro in 2023 which includes Inventories of
4.796 euro, Receivables of
5.452 euro and cash availability of
3.251 euro.
The company's Equity was valued at
-435 euro, while total Liabilities amounted to
48.823 euro.
Equity increased by 1.887 euro, from -2.328 euro in 2022, to -435 in 2023.
The Debt Ratio was 95.5% in the year 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Blutrot Medicine Srl